Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
Completed clinical trial evaluating the safety and efficacy of etanercept in patients with psoriatic arthritis treated by rheumatologists. R…
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
A completed clinical trial evaluated the safety and efficacy of etanercept in psoriatic arthritis patients treated by dermatologists, with r…
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab
Completed Greek study evaluating quality-of-life outcomes in psoriasis patients treated with adalimumab.
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis [NA]
This terminated clinical trial evaluated mechanism-based optimization of ultraviolet radiation therapy for psoriasis, with results posted in…
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: P Wave and QT Dispersion in Psoriasis
This update reports the completion of a clinical trial evaluating P wave and QT dispersion in patients with psoriasis to assess potential ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-01-16FDA Approved: CYCLOSPORINE — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for cyclosporine from Apotex Corp, authorizing changes under the generic product's regulatory fi…
-
FDA approval · 2014-01-14FDA Approved: CALCIPOTRIENE — Supplemental Application (Prasco Laboratories)
FDA records a supplemental application for calcipotriene submitted by Prasco Laboratories (NDA 020554). The submission status is AP (supplem…
-
CLINICAL_TRIALS withdrawal · 2013-12-16Clinical Trial Update: The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients [NA]
A clinical trial evaluating the effect of weight loss on the Psoriasis Area Severity Index in adults with psoriasis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis [Phase 2]
A Phase 2 trial evaluating safety and pharmacokinetics of alefacept in adolescent patients with moderate to severe psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Assessment and Tracking of Long-term Alefacept Safety
This clinical trial update reports on long-term safety monitoring for alefacept in psoriasis and notes that the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis [Phase 1]
Phase 1 safety, tolerability, pharmacokinetic, pharmacodynamic, and clinical effect data for AMG 557 in adults with psoriasis are reported; …
-
CLINICAL_TRIALS withdrawal · 2013-11-18Clinical Trial Update: Post Marketing Surveillance To Observe Safety And Efficacy Of Enbrel In Pediatric Patients With Psoriasis
This document reports the withdrawal of a post-marketing surveillance trial evaluating the safety and efficacy of Enbrel (etanercept) in ped…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of AbGn-168 in psoriasis.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis [NA]
This clinical trial update describes using UVB-311nm phototherapy after an initial slow response to adalimumab in psoriasis.
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 trial update assessing efficacy and safety of topical therapy plus etanercept in moderate to severe plaque psoriasis has completed…
-
FDA approval · 2013-10-11FDA Approved: OTREXUP — Original Application (Antares Pharma, Inc.)
FDA approved OTREXUP, a subcutaneous methotrexate injection from Antares Pharma, under an original NDA for autoimmune conditions including r…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation)
AbbVie-sponsored special investigation in patients with psoriasis vulgaris and psoriatic arthritis completed; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: Conditioning, the Placebo Effect, and Psoriasis [NA]
This document reports a completed clinical trial investigating conditioning and placebo effects in psoriasis.
-
FDA approval · 2013-09-20FDA Approved: DESOXIMETASONE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's desoximetasone for topical use under an Original Application (ANDA), expanding available generic corticosteroid opti…
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Surveillance of Humira Injection in Korean Patients
Results from a completed clinical trial evaluating Humira (adalimumab) in Korean patients with rheumatoid arthritis, psoriatic arthritis, an…
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients [Phase 1]
This is a completed Phase 1 trial evaluating the pharmacokinetics and safety of the investigational compound M518101 in patients with plaque…
-
CLINICAL_TRIALS withdrawal · 2013-08-15Clinical Trial Update: Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo. [Phase 3]
A Phase 3 trial evaluating subcutaneous secukinumab for chronic plaque psoriasis, comparing it with etanercept and placebo, has been withdra…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis [Phase 3]
Phase 3 trial evaluating whether adding methotrexate to etanercept improves efficacy and safety in psoriasis; results were posted after comp…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
An observational study update on infliximab use in ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis, and psoriasis, with th…
-
FDA approval · 2013-08-09FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved an original application for a generic fluocinonide acetonide topical product by Padagis Israel Pharmaceuticals Ltd.